Dr. Reddy's Laboratories Ltd
DRREDDY.NSIndiaAlso United States · RDY
81 filed reports · 896 financial concepts · 21 earnings calls · 15 media appearances
Filed reports
81 reports · Mar 2018 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Q1 · Financial ResultsNSE | 14 | 871 | Jun 2018 to Jun 2024 |
| Q2 · Financial ResultsNSE | 14 | 2,736 | Sep 2018 to Sep 2024 |
| Q3 · Financial ResultsNSE | 14 | 1,680 | Dec 2018 to Dec 2024 |
| Q4 · Financial ResultsNSE | 14 | 2,579 | Mar 2018 to Mar 2024 |
| Q1 · Integrated Filing (Financials)NSE | 4 | 270 | Jun 2025 to Jun 2026 |
| Q4 · Integrated Filing (Financials)NSE | 4 | 2,643 | Mar 2025 to Mar 2026 |
| AnnualNSE | 2 | 253 | Mar 2024 to Mar 2026 |
| Q2 · Integrated Filing (Financials)NSE | 2 | 1,263 | Sep 2025 |
| Q3 · Integrated Filing (Financials)NSE | 2 | 246 | Dec 2025 |
| Annual · 20-FSEC EDGAR | 8 | 5,961 | Mar 2019 to Mar 2026 |
| Interim · 6-KSEC EDGAR | 2 | 8 | Sep 2024 to Jan 2026 |
| Annual · 20-F/ASEC EDGAR | 1 | 619 | Mar 2018 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2027 Q1 | Integrated Filing (Financials) | Jun 30, 2026 | Jul 22, 2026 | 64 | Open |
| FY2027 Q1 | Integrated Filing (Financials) | Jun 30, 2026 | Jul 22, 2026 | 71 | Open |
| FY2026 | annual | Mar 31, 2026 | Jun 30, 2026 | 116 | Open |
| FY2026 | 20-F | Mar 31, 2026 | May 29, 2026 | 1,327 | Open |
| FY2026 Q4 | Integrated Filing (Financials) | Mar 31, 2026 | May 12, 2026 | 974 | Open |
| FY2026 Q4 | Integrated Filing (Financials) | Mar 31, 2026 | May 12, 2026 | 294 | Open |
| FY2026 Q3 | 6-K | Jan 21, 2026 | Jan 21, 2026 | 4 | Open |
| FY2026 Q3 | Integrated Filing (Financials) | Dec 31, 2025 | Jan 21, 2026 | 130 | Open |
| FY2026 Q3 | Integrated Filing (Financials) | Dec 31, 2025 | Jan 21, 2026 | 116 | Open |
| FY2026 Q2 | Integrated Filing (Financials) | Sep 30, 2025 | Oct 24, 2025 | 982 | Open |
| FY2026 Q2 | Integrated Filing (Financials) | Sep 30, 2025 | Oct 24, 2025 | 281 | Open |
| FY2026 Q1 | Integrated Filing (Financials) | Jun 30, 2025 | Jul 23, 2025 | 66 | Open |
Financial data
896 concepts · 19,129 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Ind As362 concepts · 11,307 facts · Mar 2018 to Jun 2026
- Amount of related party transaction1,126 · Dec 2024 to Mar 2026
- Amount of related party transaction during the reporting period566 · Mar 2025 to Mar 2026
- Value of the related party transaction as approved by the audit committee563 · Mar 2025 to Mar 2026
- Other Expense (by Nature)299 · Mar 2018 to Jun 2026
- Deferred tax120 · Mar 2018 to Jun 2026
- Depreciation & Amortization119 · Mar 2018 to Jun 2026
- Other Income119 · Mar 2018 to Jun 2026
- Pretax Income119 · Mar 2018 to Jun 2026
- Changes in inventories of finished goods work-in-progress and stock-in-trade118 · Mar 2018 to Jun 2026
- Cost of materials consumed118 · Mar 2018 to Jun 2026
- Current tax118 · Mar 2018 to Jun 2026
- Employee Benefits Expense118 · Mar 2018 to Jun 2026
- EPS (Basic)118 · Mar 2018 to Jun 2026
- EPS (Diluted)118 · Mar 2018 to Jun 2026
- EPS from Continuing Operations (Basic)118 · Mar 2018 to Jun 2026
- EPS from Continuing Operations (Diluted)118 · Mar 2018 to Jun 2026
- EPS from Discontinued Operations (Basic)118 · Mar 2018 to Jun 2026
- EPS from Discontinued Operations (Diluted)118 · Mar 2018 to Jun 2026
- Exceptional items before tax118 · Mar 2018 to Jun 2026
- Face value of equity share capital118 · Mar 2018 to Jun 2026
- Income118 · Mar 2018 to Jun 2026
- Income Tax Expense (Benefit)118 · Mar 2018 to Jun 2026
- Interest Expense118 · Mar 2018 to Jun 2026
- Inter segment revenue118 · Mar 2018 to Jun 2026
Financial506 concepts · 6,070 facts · Mar 2014 to Mar 2026
- Others44 · Mar 2017 to Mar 2026
- Cash and cash equivalents if different from statement of financial position42 · Mar 2016 to Mar 2026
- Equity40 · Mar 2016 to Mar 2026
- Intangible assets other than goodwill40 · Mar 2016 to Mar 2026
- Issued capital40 · Mar 2016 to Mar 2026
- Assets (IFRS)38 · Mar 2017 to Mar 2026
- Capital redemption reserve (IFRS)38 · Mar 2017 to Mar 2026
- Cash and cash equivalents38 · Mar 2017 to Mar 2026
- Current assets38 · Mar 2017 to Mar 2026
- Current derivative financial assets (IFRS)38 · Mar 2017 to Mar 2026
- Current derivative financial liabilities (IFRS)38 · Mar 2017 to Mar 2026
- Current investments38 · Mar 2017 to Mar 2026
- Current liabilities38 · Mar 2017 to Mar 2026
- Current portion of longterm borrowings38 · Mar 2017 to Mar 2026
- Current tax liabilities current38 · Mar 2017 to Mar 2026
- Deferred tax assets38 · Mar 2017 to Mar 2026
- Deferred tax liabilities (IFRS)38 · Mar 2017 to Mar 2026
- Equity and liabilities38 · Mar 2017 to Mar 2026
- Goodwill (IFRS)38 · Mar 2017 to Mar 2026
- Inventories38 · Mar 2017 to Mar 2026
- Investment accounted for using equity method38 · Mar 2017 to Mar 2026
- Liabilities (IFRS)38 · Mar 2017 to Mar 2026
- Longterm borrowings38 · Mar 2017 to Mar 2026
- Noncurrent assets (IFRS)38 · Mar 2017 to Mar 2026
Segment23 concepts · 1,609 facts · Mar 2016 to Jun 2026
- Revenue701 · Mar 2016 to Jun 2026
- Operating Income386 · Mar 2018 to Jun 2026
- Total Assets222 · Mar 2018 to Jun 2026
- Total Liabilities222 · Mar 2018 to Jun 2026
- Gross profit (IFRS)40 · Mar 2016 to Mar 2026
- Impairment loss13 · Mar 2021 to Mar 2026
- 1 Aurigene Discovery Technologies (Malaysia) Sdn. Bhd.4 · Mar 2024
- Total3 · Mar 2024
- 12 Dr. Reddy’s Formulations Limited2 · Mar 2024
- Revenue from sale of goods (IFRS)2 · Mar 2026
- Teva Pharmaceutical Industries Limited2 · Mar 2017
- 14 Dr. Reddy’s Laboratories Canada Inc.1 · Mar 2024
- 14 Dr. Reddy’s Laboratories Canada Inc.1 · Mar 2024
- 23 Dr. Reddy's Laboratories Taiwan Ltd.1 · Mar 2024
- 9 Dr. Reddy’s Bio-Sciences Limited1 · Mar 2024
- Ephedrine1 · Mar 2024
- Gain (loss) on sale of an intangible assets1 · Mar 2019
- gross profit margin for GG1 · Mar 2026
- Less: Effect of intercompany adjustments / eliminations1 · Mar 2024
- Less: Effect of intercompany adjustments / eliminations1 · Mar 2024
- Miscellaneous other operating income (IFRS)1 · Mar 2020
- Proprietary Products1 · Mar 2019
- Sub total1 · Mar 2024
Geography4 concepts · 142 facts · Mar 2016 to Mar 2026
- Revenue54 · Mar 2016 to Mar 2026
- India44 · Mar 2017 to Mar 2026
- Current tax expense income22 · Mar 2016 to Mar 2026
- Deferred tax expense income22 · Mar 2016 to Mar 2026
APM1 concepts · 1 facts · Mar 2026
- one-time SSA impact1 · Mar 2026
Segments
4,312 factsFigures broken down by business line, region, product or another axis the company reports on.
Related party transaction233 members · 2,252 facts
- Aurigene Discovery Technologies (Malaysia) SDN BHD with Aurigene Oncology Limited, India, Sale of goods or services12 · Dec 2024 to Mar 2026
- Aurigene Oncology Limited with Aurigene Pharmaceutical Services Limited, India, Any other transaction (Rental Income)12 · Dec 2024 to Mar 2026
- Aurigene Oncology Limited with Aurigene Pharmaceutical Services Limited, India, Interest received12 · Dec 2024 to Mar 2026
- Aurigene Oncology Limited with Clean Renewable Energy KK 2A Pvt Ltd, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Aurigene Oncology Limited with Dr.Reddy’s Foundation, Any other transaction (Contributions for social development)12 · Dec 2024 to Mar 2026
- Aurigene Oncology Limited with Greenpark Hotel and Resorts Limited, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Aurigene Oncology Limited with Stamlo Industries Limited, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Aurigene Pharmaceutical Services Limited, India with Aurigene Oncology Limited, India, Sale of goods or services12 · Dec 2024 to Mar 2026
- Aurigene Pharmaceutical Services Limited, India with Dr.Reddy’s Foundation, Any other transaction (Contributions for social development)12 · Dec 2024 to Mar 2026
- Aurigene Pharmaceutical Services Limited, India with Dr.Reddy’s Institute of Life Sciences, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Aurigene Pharmaceutical Services Limited, India with Green Park Hospitality Services Private Limited, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Aurigene Pharmaceutical Services Limited, India with Greenpark Hotel and Resorts Limited, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Aurigene Pharmaceutical Services Limited, India with Stamlo Industries Limited, Purchase of goods or services12 · Dec 2024 to Mar 2026
- betapharmArzneimittel GmbH, Germany with Dr. Reddy’s Laboratories Inc., USA, Sale of goods or services12 · Dec 2024 to Mar 2026
- betapharmArzneimittel GmbH, Germany with Dr. Reddy’s Laboratories SA, Switzerland, Interest received12 · Dec 2024 to Mar 2026
- betapharmArzneimittel GmbH, Germany with Nimbus Health GmbH, Interest received12 · Dec 2024 to Mar 2026
- betapharmArzneimittel GmbH, Germany with Reddy Pharma Iberia SA, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Bio-sciences Limited, India with DRES Energy Private Limited, Any other transaction (Rental income)12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories (Australia) Pty. Limited, Australia with Dr. Reddy’s New Zealand Limited, New Zealand, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories (EU) Limited, UK with Aurigene Pharmaceutical Services Limited, India, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories (EU) Limited, UK with Dr. Reddy’s Laboratories SA, Switzerland, Any other transaction (Other Income)12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories (EU) Limited, UK with Dr. Reddy’s Laboratories SA, Switzerland, Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories (EU) Limited, UK with Dr. Reddy’s Laboratories (UK) Limited, UK, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories Inc., USA with Aurigene Pharmaceutical Services Limited, India, Any other transaction (Other Income)12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories Inc., USA with Dr. Reddy’s Laboratories Canada, Inc., Canada, Any other transaction (Other Income)12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories Inc., USA with Dr. Reddy’s Laboratories Canada, Inc., Canada, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories Inc., USA with Dr. Reddy’s Laboratories (EU) Limited, UK, Any other transaction (Other Income)12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories Inc., USA with Dr. Reddy’s Laboratories SA, Switzerland, Any other transaction (Other Income)12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories Japan KK with Aurigene Pharmaceutical Services Limited, India, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Akhil Ravi, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Archana Bhaskar, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Aurigene Oncology Limited, India, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Aurigene Oncology Limited, India, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Aurigene Pharmaceutical Services Limited, India, Any other transaction (Commission on guarantee)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Aurigene Pharmaceutical Services Limited, India, Any other transaction (Rental income)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Aurigene Pharmaceutical Services Limited, India, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Aurigene Pharmaceutical Services Limited, India, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with betapharmArzneimittel GmbH, Germany, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Bhethanabottla S Phanimitra, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Cheminor Investments Limited, Any other transaction (Rental Expense)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Deepak Sapra, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with DRES Energy Private Limited, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with DRL Impex Limited, Any other transaction (Rental Expense)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s (Beijing) Pharmaceutical Co. Limited, China, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Bio-sciences Limited, India, Any other transaction (Rental Expense)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Farmaceutica Do Brasil Ltda., Brazil, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Farmaceutica Do Brasil Ltda., Brazil, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Formulations Limited, Any other transaction (Rental income)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Formulations Limited, Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Formulations Limited, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr.Reddy’s Foundation, Any other transaction (Contributions for social development)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr.Reddy’s Institute of Life Sciences, Any other transaction (Lab facility - Center of Excellence (CoE) for advanced and novel parenteral formulations)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr.Reddy’s Institute of Life Sciences, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories (Australia) Pty. Limited, Australia, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories Canada, Inc., Canada, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories Chile SPA., Chile, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories (EU) Limited, UK, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories Inc., USA, Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories Inc., USA, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories Inc., USA, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr.Reddy’s laboratories Jamaica Limited, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories Japan KK, Japan, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories LLC, Russia, Any other transaction (Pharmacy chain expenses reimbursement)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories LLC, Russia, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories LLC, Russia, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories LLC, Ukraine, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories LLC, Ukraine, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr Reddy’s Laboratories LLP, Kazakhstan, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr Reddy’s Laboratories LLP, Kazakhstan, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories Malaysia Sdn. Bhd., Malaysia, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy's Laboratories Philippines Inc., Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories (Proprietary) Limited, South Africa, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories SAS, Colombia, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories SA, Switzerland, Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories SA, Switzerland, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories Taiwan Limited, Taiwan, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories (UK) Limited, UK, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories (UK) Limited, UK, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy's Nestle and Health Science Limited, Any other transaction (Manpower services provided by DRL India)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy's Nestle and Health Science Limited, Any other transaction (Marketing and promotional services provided by DRL India)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy's Nestle and Health Science Limited, Any other transaction (Royalty Income)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy's Nestle and Health Science Limited, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy's Nestle and Health Science Limited, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s New Zealand Limited, New Zealand, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Srl, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s (Thailand) Limited, Thailand, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Erez Israeli, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with G Anuradha, Any other transaction (Lease rentals paid under cancellable operating leases)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with G.Mallika Reddy, Any other transaction (Lease rentals paid under cancellable operating leases)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Green Park Hospitality Services Private Limited, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Greenpark Hotel and Resorts Limited, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with G V Prasad, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with G.V.Sanjana Reddy, Any other transaction (Lease rentals paid under cancellable operating leases)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Idea2enterprises (India) Private Limited, Any other transaction (Rental Expense)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Indian School of Business, Any other transaction (Campus placement, training and development services)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Indus Projects Private Limited, Any other transaction (Civil works)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Industrias Quimicas Falcon de Mexico, S.A.de C.V, Mexico, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Industrias Quimicas Falcon de Mexico, S.A.de C.V, Mexico, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Jayanth Sridhar, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with K Deepti Reddy, Any other transaction (Lease rentals paid under cancellable operating leases)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Krishna Venkatesh, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with K Samrajyam, Any other transaction (Lease rentals paid under cancellable operating leases)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with K Satish Reddy, Any other transaction (Lease rentals paid under cancellable operating leases)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with K Satish Reddy, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Kumar Randhir Singh, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Kunshan Rotam Reddy Pharmaceuticals, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Mannam Venkata Narasimham, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Milan Kalawadia, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with M V Ramana, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Naandi Foundation, Any other transaction (Contributions for social development)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with NICE Foundation, Any other transaction (Contributions for social development)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Patrick Aghanian, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Reddy Pharma Iberia SAU, Spain, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Reddy Pharma SAS, France, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Sanjay Sharma, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Shravya Reddy Kallam, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Stamlo Industries Limited, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Sushrut Kulkarni, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Svaas Wellness Limited, India, Purchase of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Vishal Reddy, Remuneration12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Wildlife Trust of India, Any other transaction (Contributions for social development)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Zenfold Sustainable Technologies Private Limited, Any other transaction (Purchase)12 · Dec 2024 to Mar 2026
- Dr. Reddy's Laboratories Limited with Zenfold Sustainable Technologies Private Limited, Any other transaction (Sale)12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories Romania SRL with Dr. Reddy’s Laboratories SA, Switzerland, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SAS, Colombia with Dr. Reddy's Laboratories Chile SPA., Chile, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with betapharmArzneimittel GmbH, Germany, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s Laboratories (Australia) Pty. Limited, Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s Laboratories Canada, Inc., Canada, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s Laboratories Chile SPA., Chile, Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s Laboratories Inc., USA, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s Laboratories Kazakhstan LLP, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s Laboratories LLC, Russia, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s Laboratories LLC, Ukraine, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy's Laboratories Philippines Inc., Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s Laboratories (Proprietary) Limited, South Africa, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s Laboratories Romania SRL, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s Laboratories SAS, Colombia, Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy`s Research and Development B.V., Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s (Thailand) Limited, Thailand, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Northstar OpCo, Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Northstar Switzerland SARL, Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Reddy Pharma Iberia SA, Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Laboratories (UK) Limited, UK with Dr. Reddy’s Laboratories SA, Switzerland, Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Srl with Dr. Reddy’s Laboratories SA, Switzerland, Interest received12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Srl with Reddy Pharma Iberia SA, Sale of goods or services12 · Dec 2024 to Mar 2026
- Industrias Quimicas Falcon de Mexico, S.A.de C.V, Mexico with Aurigene Pharmaceutical Services Limited, India, Sale of goods or services12 · Dec 2024 to Mar 2026
- Industrias Quimicas Falcon de Mexico, S.A.de C.V, Mexico with Dr. Reddy’s Laboratories Inc., USA, Sale of goods or services12 · Dec 2024 to Mar 2026
- Industrias Quimicas Falcon de Mexico, S.A.de C.V, Mexico with Dr. Reddy’s Laboratories SA, Switzerland, Sale of goods or services12 · Dec 2024 to Mar 2026
- Lacock Holdings Limited with Dr. Reddy’s Laboratories SA, Switzerland, Interest received12 · Dec 2024 to Mar 2026
- Reddy Netherlands B.V. with Dr. Reddy`s Research and Development B.V. (formerly Octoplus BV), Interest received12 · Dec 2024 to Mar 2026
- Reddy Pharma SAS, France with Dr. Reddy’s Laboratories SA, Switzerland, Interest received12 · Dec 2024 to Mar 2026
- Reddy Pharma SAS, France with Reddy Pharma Iberia SA, Sale of goods or services12 · Dec 2024 to Mar 2026
- Dr. Reddy’s Farmaceutica Do Brasil Ltda. with Dr. Reddy's Laboratories Chile SPA., Chile, Sale of goods or services8 · Jun 2025 to Mar 2026
- Dr. Reddy’s Laboratories (Canada) Inc. with Dr. Reddy’s Laboratories Inc., USA, Any other transaction (Other Income)8 · Jun 2025 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Formulations Limited, Loan8 · Dec 2024 to Sep 2025
- Dr. Reddy's Laboratories Limited with Dr.Reddy’s Institute of Life Sciences, Any other transaction (Annual facility maintenance cost Vaccine Development Lab)8 · Jun 2025 to Mar 2026
- Dr. Reddy's Laboratories Limited with Kunshan Rotam Reddy Medical Company, Sale of goods or services8 · Jun 2025 to Mar 2026
- Dr. Reddy's Laboratories Limited with PAGE Foundation, Any other transaction (Contributions for social development)8 · Dec 2024 to Sep 2025
- Dr. Reddy’s Laboratories SA, Switzerland with Dr Reddy's Denmark ApS, Interest received8 · Jun 2025 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr Reddy's Denmark ApS, Sale of goods or services8 · Jun 2025 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s Laboratories (UK) Limited, Sale of goods or services8 · Jun 2025 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Dr.Reddy’s Netherlands BV, Sale of goods or services8 · Jun 2025 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with North Star OpCo Limited, Any other transaction (Other Income)8 · Jun 2025 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with North Star Sweden AB, Interest received8 · Jun 2025 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Northstar Switzerland SARL, Any other transaction (Other Income)8 · Jun 2025 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Reddy Pharma Iberia SAU, Spain, Sale of goods or services8 · Jun 2025 to Mar 2026
- Dr. Reddy’s Laboratories SA, Switzerland with Reddy Pharma SAS, France, Sale of goods or services8 · Jun 2025 to Mar 2026
- Dr. Reddy’s Laboratories (UK) Limited, UK with Dr. Reddy’s Laboratories (Australia) Pty. Limited, Australia, Sale of goods or services8 · Jun 2025 to Mar 2026
- Dr. Reddy’s Laboratories (UK) Limited, UK with Dr. Reddy’s Laboratories SA, Switzerland, Sale of goods or services8 · Dec 2024 to Sep 2025
- Dr. Reddy`s Research and Development B.V. (formerly Octoplus BV) with Dr. Reddy’s Laboratories Romania SRL, Sale of goods or services8 · Dec 2024 to Sep 2025
- Dr. Reddy`s Research and Development B.V. with Dr. Reddy’s Laboratories SA, Switzerland, Any other transaction (Other Income)8 · Jun 2025 to Mar 2026
- Dr. Reddy`s Research and Development B.V. with Reddy Netherlands B.V., Interest received8 · Dec 2024 to Sep 2025
- North Star OpCo Limited with Dr. Reddy’s Laboratories SA, Switzerland, Interest received8 · Jun 2025 to Mar 2026
- North Star OpCo Limited with Dr. Reddy’s Laboratories (UK) Limited, UK, Any other transaction (Other Income)8 · Jun 2025 to Mar 2026
- Northstar Switzerland SARL with Dr. Reddy’s Laboratories SA, Switzerland, Interest received8 · Jun 2025 to Mar 2026
- Reddy Pharma Iberia SAU, Spain with betapharmArzneimittel GmbH, Germany, Sale of goods or services8 · Dec 2024 to Sep 2025
- Reddy Pharma Iberia SAU, Spain with Dr. Reddy’s Srl, Sale of goods or services8 · Jun 2025 to Mar 2026
- Reddy Pharma SAS, France with betapharmArzneimittel GmbH, Germany, Sale of goods or services8 · Dec 2024 to Sep 2025
- Aurigene Oncology Limited with Clean Renewable Energy KK 2A Pvt Ltd, Investment4 · Dec 2024 to Mar 2025
- betapharmArzneimittel GmbH, Germany with Dr. Reddy’s Laboratories SA, Switzerland, Loan4 · Dec 2024 to Mar 2025
- betapharmArzneimittel GmbH, Germany with Dr. Reddy’s Srl, Sale of goods or services4 · Dec 2024 to Mar 2025
- betapharmArzneimittel GmbH, Germany with Nimbus Health GmbH, Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories (EU) Limited, UK with Dr. Reddy’s Laboratories SA, Switzerland, Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Aakar Asha Charitable Trust, Any other transaction (Contributions for social development)4 · Dec 2025 to Mar 2026
- Dr. Reddy's Laboratories Limited with Ahimsa Trust, Any other transaction (Contributions for social development)4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Araku Originals Private Limited, Any other transaction (Purchase of coffee Machine)4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Aurigene Oncology Limited, India, Interest received4 · Dec 2025 to Mar 2026
- Dr. Reddy's Laboratories Limited with Aurigene Oncology Limited, Investment4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Aurigene Pharmaceutical Services Limited, India, Interest received4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Aurigene Pharmaceutical Services Limited, India, Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with betapharmArzneimittel GmbH, Germany, Purchase of goods or services4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with DRL Impex Limited, Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s (Beijing) Pharmaceutical Co. Limited, China, Sale of goods or services4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Bio-sciences Limited, India, Investment4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr.Reddy’s Institute of Life Sciences, Any other transaction (Sale of D.G.Set at Scrap Value)4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr.Reddy’s Institute of Life Sciences, Any other transaction (Setting up of Vaccine Development Lab)4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories (EU) Limited, UK, Sale of goods or services4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories Louisiana LLC, USA, Purchase of goods or services4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories Louisiana LLC, USA, Sale of goods or services4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories New York, LLC, Any other transaction (Asset purchase)4 · Dec 2025 to Mar 2026
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories SA, Switzerland, Investment4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy’s Laboratories Taiwan Limited, Taiwan, Sale of goods or services4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy's Nestle and Health Science Limited, Any other transaction (Transfer of Assets & Liabilities, Cross Charge of Pre incorporation spends, License of Selected Brands)4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy's Nestle and Health Science Limited, Interest received4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy's Nestle and Health Science Limited, Investment4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy's Nestle and Health Science Limited, Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy`s Research and Development B.V. (formerly Octoplus BV), Sale of goods or services4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Dr. Reddy`s Research and Development B.V., Purchase of goods or services4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Imperial Credit Private Limited, India, Investment4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Industrias Quimicas Falcon de Mexico, S.A.de C.V, Mexico, Investment4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with International Foundation for Research and Education, Any other transaction (Contributions for social development)4 · Dec 2025 to Mar 2026
- Dr. Reddy's Laboratories Limited with IOSYNTH LABS PRIVATE LIMITED, Purchase of goods or services4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Marc Kikuchi, Remuneration4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Nayanta Education Foundation, Any other transaction (Contributions for social development)4 · Dec 2025 to Mar 2026
- Dr. Reddy's Laboratories Limited with O2 Renewable Energy IX Private Limited, Investment4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Parag Agarwal, Remuneration4 · Dec 2024 to Mar 2025
- Dr. Reddy's Laboratories Limited with Promius Pharma LLC, USA, Sale of goods or services4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories Louisiana LLC with Dr. Reddy’s Laboratories Inc., USA, Sale of goods or services4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories Louisiana LLC with Dr. Reddy’s Laboratories SA, Switzerland, Sale of goods or services4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy’s Laboratories (Australia) Pty. Limited, Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy`s Research and Development B.V. (formerly Octoplus BV), Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy's Venezuela, C.A., Interest received4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories SA, Switzerland with Dr. Reddy's Venezuela, C.A., Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories SA, Switzerland with Lacock Holdings Limited, Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories SA, Switzerland with Northstar OpCo, Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories SA, Switzerland with Northstar Switzerland SARL, Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories SA, Switzerland with Reddy Pharma Iberia SA, Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories (UK) Limited, UK with Dr. Reddy’s Laboratories SA, Switzerland, Loan4 · Dec 2024 to Mar 2025
- Dr. Reddy’s Laboratories (UK) Limited, UK with Reddy Pharma Iberia SA, Sale of goods or services4 · Jun 2025 to Sep 2025
- Dr. Reddy`s Research and Development B.V. (formerly Octoplus BV) with Reddy Netherlands B.V., Loan4 · Dec 2024 to Mar 2025
- Industrias Quimicas Falcon de Mexico, S.A.de C.V, Mexico with Dr. Reddy’s Laboratories (EU) Limited, UK, Sale of goods or services4 · Dec 2024 to Mar 2025
- Reddy Netherlands B.V. with Dr. Reddy`s Research and Development B.V. (formerly Octoplus BV), Loan4 · Dec 2024 to Mar 2025
- Svaas Wellness Limited, India with Callhealth Services Private Limited, Any other transaction (Diagnostic Aggregator Partner Online GP partner)4 · Dec 2024 to Mar 2025
Reportable segments9 members · 386 facts
- Global Generics102 · Mar 2018 to Jun 2026
- Pharmaceutical Services and Active Ingredients102 · Mar 2018 to Jun 2026
- Proprietary Products74 · Mar 2018 to Sep 2025
- Others60 · Mar 2018 to Jun 2026
- c) Others16 · Mar 2024 to Jun 2026
- a) Pharmaceutical Services and Active Ingredients9 · Mar 2024 to Mar 2025
- b) Global Generics9 · Mar 2024 to Mar 2025
- a) Global Generics7 · Sep 2025 to Jun 2026
- b) Pharmaceutical Services and Active Ingredients7 · Sep 2025 to Jun 2026
Reportable segments finance costs9 members · 386 facts
- Global Generics102 · Mar 2018 to Jun 2026
- Pharmaceutical Services and Active Ingredients102 · Mar 2018 to Jun 2026
- Proprietary Products74 · Mar 2018 to Sep 2025
- Others60 · Mar 2018 to Jun 2026
- c) Others16 · Mar 2024 to Jun 2026
- a) Pharmaceutical Services and Active Ingredients9 · Mar 2024 to Mar 2025
- b) Global Generics9 · Mar 2024 to Mar 2025
- a) Global Generics7 · Sep 2025 to Jun 2026
- b) Pharmaceutical Services and Active Ingredients7 · Sep 2025 to Jun 2026
Segments16 members · 376 facts
- Pharmaceutical Services And Active Ingredient113 · Mar 2016 to Mar 2026
- Global Generic111 · Mar 2016 to Mar 2026
- Global Generics68 · Mar 2016 to Mar 2026
- Pharmaceutical Services And Active Ingredients24 · Mar 2016 to Mar 2026
- Other22 · Mar 2016 to Mar 2026
- Proprietary Product14 · Mar 2016 to Mar 2022
- Proprietary Products9 · Mar 2017 to Mar 2022
- Others Segments6 · Mar 2017 to Mar 2022
- Immutep2 · Mar 2026
- Ephedrine1 · Mar 2024
- Global Generics And Other1 · Mar 2021
- Nuvaring1 · Mar 2025
- Other Segments1 · Mar 2024
- Saxagliptin1 · Mar 2024
- Teva Pharmaceutical Industries Limited1 · Mar 2017
- Xenoport Inc1 · Mar 2017
Reportable segment assets9 members · 222 facts
- Global Generics59 · Mar 2018 to Jun 2026
- Pharmaceutical Services and Active Ingredients59 · Mar 2018 to Jun 2026
- Proprietary Products41 · Mar 2018 to Sep 2025
- Others36 · Mar 2018 to Jun 2026
- c) Others9 · Mar 2024 to Jun 2026
- a) Pharmaceutical Services and Active Ingredients5 · Mar 2024 to Mar 2025
- b) Global Generics5 · Mar 2024 to Mar 2025
- a) Global Generics4 · Sep 2025 to Jun 2026
- b) Pharmaceutical Services and Active Ingredients4 · Sep 2025 to Jun 2026
Reportable segment liabilities9 members · 222 facts
- Global Generics59 · Mar 2018 to Jun 2026
- Pharmaceutical Services and Active Ingredients59 · Mar 2018 to Jun 2026
- Proprietary Products41 · Mar 2018 to Sep 2025
- Others36 · Mar 2018 to Jun 2026
- c) Others9 · Mar 2024 to Jun 2026
- a) Pharmaceutical Services and Active Ingredients5 · Mar 2024 to Mar 2025
- b) Global Generics5 · Mar 2024 to Mar 2025
- a) Global Generics4 · Sep 2025 to Jun 2026
- b) Pharmaceutical Services and Active Ingredients4 · Sep 2025 to Jun 2026
Details of other expenses9 members · 181 facts
- Selling and other expenses82 · Mar 2018 to Jun 2024
- Impairment of non-current assets27 · Dec 2019 to Jun 2024
- Other expenses24 · Mar 2024 to Jun 2026
- Impairment of non-current assets, net13 · Mar 2024 to Jun 2026
- Impairment of non current assets12 · Mar 2021 to Sep 2025
- Impairment of non current assets, net9 · Mar 2024 to Jun 2026
- Other Expenses8 · Sep 2024 to Mar 2026
- Selling and Other Expenses4 · Sep 2018
- Impairment of non- current assets,net2 · Mar 2025
Geographical areas15 members · 142 facts
- Country Of Domicile22 · Mar 2016 to Mar 2026
- Foreign Countries22 · Mar 2016 to Mar 2026
- India Country19 · Mar 2017 to Mar 2026
- Oncology13 · Mar 2017 to Mar 2023
- Other Countries10 · Mar 2017 to Mar 2026
- Others Countries Country10 · Mar 2017 to Mar 2026
- Russia Country10 · Mar 2017 to Mar 2026
- Switzerland Country9 · Mar 2018 to Mar 2026
- India5 · Mar 2016 to Mar 2018
- United States5 · Mar 2016 to Mar 2018
- US5 · Mar 2022 to Mar 2026
- USD4 · Mar 2023 to Mar 2026
- Others Countries3 · Mar 2016 to Mar 2018
- Russia3 · Mar 2016 to Mar 2018
- Switzerland2 · Mar 2017 to Mar 2018
Items that will be reclassified to profit and loss4 members · 54 facts
- Items that will be reclassified subsequently to profit or loss25 · Jun 2022 to Mar 2026
- Items that will be reclassified to profit or loss20 · Sep 2022 to Jun 2026
- b) (i) Items that will be reclassified subsequently to profit or loss6 · Mar 2024 to Sep 2025
- (i) Items that will be reclassified subsequently to profit or loss3 · Dec 2025 to Jun 2026
Items that will not be reclassified to profit and loss4 members · 49 facts
- Items that will not be reclassified subsequently to profit or loss25 · Jun 2022 to Mar 2026
- Items that will not be reclassified to profit or loss15 · Sep 2022 to Mar 2026
- a) (i) Items that will not be reclassified subsequently to profit or loss6 · Mar 2024 to Sep 2025
- (i) Items that will not be reclassified subsequently to profit or loss3 · Dec 2025 to Jun 2026
Subsidiary6 members · 14 facts
- Amount5 · Mar 2024
- Investments3 · Mar 2024
- Other liabilities2 · Mar 2024
- Reserves & surplus2 · Mar 2024
- Provision for Taxation1 · Mar 2024
- Share Capital1 · Mar 2024
Other current financial liabilities4 members · 6 facts
- Lease liabilities2 · Mar 2026
- Other financial liabilities2 · Mar 2026
- Derivative financial instruments1 · Mar 2026
- Derivative instruments1 · Mar 2026
Other current financial assets3 members · 4 facts
- Other financial assets2 · Mar 2026
- Derivative financial instruments1 · Mar 2026
- Derivative instruments1 · Mar 2026
Other noncurrent assets2 members · 4 facts
- Other non-current assets2 · Mar 2026
- Tax assets, net2 · Mar 2026
Other noncurrent financial liabilities2 members · 3 facts
- Lease liabilities2 · Mar 2026
- Other financial liabilities1 · Mar 2026
Revenue segment3 members · 3 facts
- (`)1 · Mar 2024
- ₹1 · Mar 2026
- US$1 · Mar 2024
Other current assets1 member · 2 facts
- Other current assets2 · Mar 2026
Other current liabilities1 member · 2 facts
- Other current liabilities2 · Mar 2026
Other noncurrent financial assets2 members · 2 facts
- Other financial assets1 · Mar 2026
- Other non-current financial assets1 · Mar 2026
Other noncurrent liabilities1 member · 2 facts
- Other non-current liabilities2 · Mar 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Management discussion (MD&A) commentary36 claims from 2 reports · Mar 2025 to Mar 2026
- Risk-factor changes12 claims from 1 reports · Mar 2026
- Risk factors94 risks from 2 annual reports · 2025 to 2026
Earnings calls
21 calls · Jul 2021 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2027 Q1Jul 28, 2026
- FY2026 Q4Apr 27, 2026
- FY2026 Q3Jan 21, 2026
- FY2026 Q2Oct 24, 2025
- FY2026 Q1Jul 23, 2025
- FY2025 Q4May 9, 2025
- FY2025 Q3Jan 23, 2025
- FY2025 Q2Nov 5, 2024
- FY2025 Q1Jul 27, 2024
- FY2024 Q4May 7, 2024
- FY2024 Q3Jan 30, 2024
- FY2024 Q2Oct 27, 2023
- FY2024 Q1Jul 26, 2023
- FY2023 Q4May 11, 2023
- FY2023 Q3Jan 25, 2023
- FY2023 Q2Oct 28, 2022
Executive media
15 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances6 · Nov 2023 to Aug 2025
- TV interviews6 · Jan 2020 to May 2026
- Conference talks3 · Jul 2022 to Jul 2026
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.